Skip to Main Content
Title
Assessing potential prescription reimbursement changes: estimated acquisition costs in Wisconsin.
First Author
Kreling, David H
Date of Pub
1989 Spring
Pages
67-75
Volume
10
Issue
3
Other Authors
N/A
Abstract
Potential impacts from two methods of changing prescription drug ingredient reimbursement in the Wisconsin Medicaid program were estimated. Current reimbursement amounts were compared with those resulting from either direct prices for eight manufacturers' products and average wholesale price less 10.5 percent for other products or wholesaler cost plus 5.01 percent for all products. The resulting overall average ingredient cost reimbursement reductions were 6.64 percent ($0.56 per prescription) and 6.94 percent ($0.59 per prescription) for the two methods, respectively. The results should be viewed from the perspective of both program savings and reduced pharmacists' revenues.
Abstract Continued
N/A
MeSH
Comparative Study : Costs and Cost Analysis/statistics & numerical data : Data Collection : Insurance, Pharmaceutical Services/statistics & numerical data : Medicaid/statistics & numerical data : Prescriptions, Drug/economics : Reimbursement Mechanisms/economics : Support, Non-U.S. Gov't : Wisconsin
NTIS Number
PB89-208953